Delivery Order SPE2DB20D3103-SPE2DB23FP0B8

Award Date 7/17/23
Potential Completion Date 7/18/23
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,567,645,335 units of GLUCAGON 1 MG EMERGENCY KITS. The contract, valued at $1,379.68, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 21, 2025. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award is for the delivery of 4,565,265,938 units of GLUCAGON 1 MG EMERGENCY KITS, with a ceiling value of $11,329.00. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 29, 2024. This contract is not set aside for any specific...
This federal contract award is for the delivery of 4,564,478,873 units of Glucagon 1 mg Emergency Kits to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, under a Delivery Order with a Firm Fixed Price of $9,268.80 and a completion date of May 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA...
This federal contract award is for the delivery of 4,562,939,999 units of Glucagon 1 mg emergency kits. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, and has a total ceiling value of $10,362.76. The contract is a delivery order with a firm fixed price pricing type, and the ultimate completion date is November 30, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, to provide 4,563,756,316 Glucagon 1 mg emergency kits. The total potential value of the award is $2,729.14. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver...
This federal contract award is for the delivery of Glucagon 1 mg emergency kits to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,766.06 and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the...
This federal contract award is for the delivery of 4,564,160,504 Glucagon 1 mg Emergency Kits to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a firm fixed price of $7,420.88 and a period of performance through April 4, 2024. This award is a delivery order under a larger indefinite delivery contract (IDC) held...
This federal contract award is for the delivery of 4,565,220 units of Glucagon 1 mg Emergency Kits to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $5,196.90. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 23, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds several large Indefinite...
This federal contract award is for the delivery of 4,564,184,396 Glucagon 1 mg emergency kits to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a ceiling value of $5,258.40 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of 4,565,224,427 Glucagon 1 mg Emergency Kits to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, through a Delivery Order (SPE2DX24F1VEZ) under an Indefinite Delivery Contract (SPE2DX15D7056) valued at up to $999,999,999 through December 2025. The contract has a ceiling value of $3,259.33 and a period of performance ending on July 24, 2024. This...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP0B8
    Delivery Order

This federal contract award is for the delivery of 4,561,520,228 units of Glucagon 1 mg Emergency Kits to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,886.76 and a period of performance through July 18, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:59 AM